Smith Graham & Co Investment Advisors’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
Other funds holding LH
Smith Graham & Co Investment Advisors's LH Position: Q4 2023 in Review
Smith Graham & Co Investment Advisors reduced its Labcorp (LH) stake by 9.3% in Q4 2023, selling an estimated $276K and leaving 12,793 shares worth $2.91M. The position accounts for 0.34% of the portfolio, ranked #132.
Smith Graham & Co Investment Advisors first reported a position in LH in Q3 2017 and has held it in 26 quarters since. The position peaked at $5.27M in Q1 2021. 956 funds tracked by Wall St. Rank hold LH as of Q4 2023.
- Smith Graham & Co Investment Advisors held 12,793 shares of Labcorp worth $2.91M as of Q4 2023.
- Smith Graham & Co Investment Advisors sold 1,312 Labcorp shares in Q4 2023, an estimated $276K.
- Labcorp made up 0.34% of Smith Graham & Co Investment Advisors's portfolio in Q4 2023, its #132 holding.
- Smith Graham & Co Investment Advisors first reported a position in Labcorp in Q3 2017 and has held it in 26 quarters since.
- Smith Graham & Co Investment Advisors's Labcorp position peaked at $5.27M in Q1 2021.
- 956 funds tracked by Wall St. Rank held Labcorp as of Q4 2023.
Based on Smith Graham & Co Investment Advisors's 13F filing for Q4 2023, filed 29 Jan 2024.